Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tessa Dieckman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|August 3, 2022
Celiac disease: New therapies on the horizonTessa Dieckman, Frits Koning, Gerd Bouma
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2024
Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical StudyTessa Dieckman, Michael Schumann, Hanneke Beaumont, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2024
ReplyTessa Dieckman, Michael Schumann, Hanneke Beaumont, et al.
Gene|November 15, 2019
Celiac disease associated SNP rs17810546 is located in a gene silencing regionAntonie Zwiers, Roy L J van Wanrooij, Tessa Dieckman, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 26, 2022
Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell HeterogeneityTessa Dieckman, Mette Schreurs, Ahmed Mahfouz, et al.
Gastro Hep Advances|January 13, 2025
Activated CD27<sup>+</sup>PD-1<sup>+</sup> CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type IITessa Dieckman, Mette Schreurs, Ciska Lindelauf, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|August 3, 2022
Celiac disease: New therapies on the horizonTessa Dieckman, Frits Koning, Gerd Bouma
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2024
Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical StudyTessa Dieckman, Michael Schumann, Hanneke Beaumont, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2024
ReplyTessa Dieckman, Michael Schumann, Hanneke Beaumont, et al.
Gene|November 15, 2019
Celiac disease associated SNP rs17810546 is located in a gene silencing regionAntonie Zwiers, Roy L J van Wanrooij, Tessa Dieckman, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 26, 2022
Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell HeterogeneityTessa Dieckman, Mette Schreurs, Ahmed Mahfouz, et al.
Gastro Hep Advances|January 13, 2025
Activated CD27<sup>+</sup>PD-1<sup>+</sup> CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type IITessa Dieckman, Mette Schreurs, Ciska Lindelauf, et al.
Pageof 1